Ophthalmic Genetics

Ophthalmic genetics includes determination of patterns and risks of inheritance and development of treatments for genetic diseases. Vitamin A deficiency is the leading cause of preventable blindness in children worldwide and results in a well-recognized ocular phenotype. It is also includes the several technique in correcting the defective gene by using application of biotechnology techniques such as gene therapy. Ophthalmic genetics or ophthalmic gene therapy can process through by following methods like ocular gene transfer methods. They have been several diseases which have been cured by gene therapy like retinitis pigmentosa and ARMD.

 

 

  • Abnormalities of Nuclear or Mitochondrial DNA
  • Autosomal dominant disorders
  • Autosomal recessive disorders
  • X-linked recessive disorders
  • Matrilineal inheritance
  • Chromosomal Abnormalities

Related Conference of Ophthalmic Genetics

May 09-10, 2024

7th International Eye and Vision Congress

Barcelona, Spain
May 16-17, 2024

8th World Congress on Eye and Vision

Rome, Italy
June 13-14, 2024

9th International Conference on Eye and Vision

Barcelona, Spain
September 12-13, 2024

5th International Conference on Optometry

Paris, France
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain
October 17-18, 2024

24th Global Ophthalmologists Annual Meeting

London, UK

Ophthalmic Genetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in